ACTRN12608000605392尚未招募未知
A phase 1 trial of exercise for patients admitted to hospital with acute exacerbation of chronic obstructive pulmonary disease (COPD)- the safety and feasibility of exercise programme.
Clarice Youci Tang0 个研究点目标入组 30 人开始时间: 2008年12月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 100 Years(—)
- 性别
- All
入选标准
- •1. A primary admission diagnosis of acute exacerbation of COPD, or pneumonia or chest infection with a past medical history of COPD
- •- All levels of severity will be considered
- •2. Able to ambulate independently or with minimal assistance of one person with/without a gait aid.
- •3. Able to obey two-stage commands, obtain a score of 15 on the Glasgow Coma Scale, be orientated to time, day and date and have no previous documented diagnosis of dementia
- •4. Patients are managed on the general medical wards.
- •5. Patients that are spontaneously ventilating and do not required any continuous assistance with ventilation.
- •6. Able to give informed consent to participate in the trial.
- •7. Must obtain approval of supervising medical officer that patient can participate in trial
排除标准
- •1. Patients who are clinically unstable as defined by below
- •- Presence of hyperthermia (temperature of =380 Celsius)
- •- Systolic pressure of <90 or >170mmHg
- •- Diastolic pressure of >120mmHg
- •- Unconscious or patients in a delirious state
- •- Patients with severe respiratory acidosis with a blood pH < 7.3 (McKenzie et al., 2007)
- •- Patients measured to have an acute cardiac arrhythmia during admission.
- •- Patients who are tachycardiac with a resting heart rate >120 beats per minute.
- •2. Patients with other co-morbidities that may impair the ability to participate in an exercise programme (for example severe osteoarthritis, severe neurological conditions with residual deficits, severe low back pain and acute musculoskeletal injuries).
- •3. Patients who are acutely confused and unable to follow simple instructions.
- •4. - Patients admitted to the intensive care unit.
- •- Patients admitted to short stay unit or Rapid Acute Medical Unit (RAMU)
- •5. Patients that required intubation and mechanical ventilation and/or admitted into intensive care.
- •6. Patients from a high-level or palliative care facility
研究者
相似试验
已完成
不适用
BRAin Cancer and Exercise (BRACE) Study.Brain CancerCancer - BrainACTRN12617001577303Haematology & Oncology Clinics of Australia Research Centre Ltd (Trading as Icon Cancer Foundation)12
已完成
1 期
A Trial in Healthy Participants to Evaluate the Pharmacokinetics, Safety, Tolerability and Food Effects of Multiple Forms of PRAX-114.DepressionACTRN12620000522910Praxis Precision Medicines Australia, Pty Ltd85
已完成
1 期
A Trial in Healthy Participants to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRAX-944Essential TremorNeurological - Other neurological disordersACTRN12620000675921Praxis Precision Medicines24
已完成
不适用
A phase 1 study in healthy volunteers to determine the dermatopharmacokinetics of topically applied diclofenac in combination with the novel penetration enhancer Tocopheryl Phosphate Mixture (TPM), compared with Votaren(registered trademark) gelMuscular or joint pain relief in healthy volunteers currently experiencing no painOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12609000505202Phosphagenics Limited24
进行中(未招募)
1 期
Study of safety and efficacy of genome-edited hematopoietic stem and progenitor cells in sickle cell disease (SCD)EUCTR2019-003489-41-ITOVARTIS PHARMA AG30
